Polymorphisms of XRCC2 Gene Were Associated with Susceptibility of Lung Cancer

WANG Rui,ZENG Hui,LI Yan,WANG Na,ZHANG Jian-hui,LIU Jun-feng
DOI: https://doi.org/10.3781/j.issn.1000-7431.2007.02.011
2007-01-01
Tumori
Abstract:Objective: To investigate the possible association of functional C41657T and G4234C polymorphisms of XRCC2 genes with susceptibility of lung cancer in Northern Chinese population. Methods:The single nucleotide polymorphisms (SNP) in XRCC2 C41657T and G4234C were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis in 199 patients with lung cancer, and 200 healthy controls. The genotype and allele distribution were compared and their contribution to the risk of lung cancer were analyzed. Results: The genotype (CC, CT, and TT) and allele distribution of the XRCC2 C41657T and G4234C SNP in the patients with lung cancer was not significantly different compared with that in healthy controls (all P0.05). When the two XRCC2 SNP were combined, the haplotype distribution in lung cancer patients was not significantly different from that in healthy controls (P0.05). When stratified for histological type, smoking status, and age, compared with C/C genotype, combination of C/T and T/T genotypes of XRCC2 C41657T increased the risk of developing adenosquamous carcinoma (OR=2.95, 95%CI=1.15-7.59), and the individuals with C/T genotype of XRCC2 C41657T had the increased risk of developing lung cancer in non smokers (OR=2.12,95%CI=1.05-4.27). Compared with G/G genotype, the combination of G/C and C/C of XRCC2 G4234C and G/C genotype both increased the risk of developing small cell lung cancer (OR=2.82 and 2.82;95%CI=1.15-6.91 and 1.17-6.76). For old subjects (age≥60 years), the combination of G/C and C/C of G4234C and G/C genotype both increased the risk of developing lung cancer(OR=2.29 and 2.37;95%CI=1.11-4.72 and 1.16-4.88). Conclusions:For XRCC2 C41657T, both heterozygote and homozygote T carriers have the increased risk of developing adenosquamous carcinoma, the heterozygote CT carriers have the increased risk of developing lung cancer in non smokers. For G4234C, both heterozygote and homozygote C carriers have the increased risk of developing lung cancer in old subjects (age≥60 years) and of small cell lung cancer in Northern Chinese population.
What problem does this paper attempt to address?